Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma

NEXT STORY
Global Microcrystalline Cellulose (MCC) Industry
PREV STORY
North America Airway Clearance System Market (2020 to 2025) – by Type, Application, End-use and Country
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Curis Announces Upcoming Presentation at the American Society of Hematology 59th Annual Meeting & Exposition

LEXINGTON, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

author_avatar
NASDAQ Market News

Biocartis Group NV: Biocartis Establishes R&D Center in the US

  PRESS RELEASE: 1 March 2018, 07:01 CET Biocartis Establishes R&D Center in the US ...

author_avatar
NASDAQ Market News

Invitation: Terveystalo Plc Q3 result – webcast and conference call on 14 November 2018

Terveystalo Plc will publish its Interim report for January-September 2018 on 14 November at ...

author_avatar
NASDAQ Market News